SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
410Ciphergen technology could be used to detect SARS. SELDI could be used to identbunn-2/1/2006
409Ciphergen (CIPH) crosses above 200 Day Moving Average. On a technical basis Ciphbunn-1/30/2006
408[SELDI for diagnosis of Multiple Sclerosis] >>Ann Neurol. 2006 Jan 25;59(tuck-1/27/2006
407Dr Fung with Ciphergen making presentation next week. Maybe an update on Ovarianbunn-1/26/2006
406Ciphergen NR- In compliance with Nasdaq!bunn-1/24/2006
405[SELDI for early detection of SARS] >>Clin Chem. 2006 Jan 19; [Epub aheadtuck-1/22/2006
404Diagnostic Test For Ovarian Cancer? Both Quest & the Ceo for Ciphergen are bunn-1/22/2006
403J Thromb Haemost. 2006 Feb;4(2):333-8. A rapid test for the diagnosis of thromtuck-1/20/2006
402Ciphergen appears to be on track towards relisting. Having filed financial stattuck-1/20/2006
401[SELDI for proteomics of gastric carcinoma and its clinical significance] >&tuck-1/19/2006
400[SELDI for proteomic profiling of mature CD10+ B-cell lymphomas] >>Am J Ctuck-1/19/2006
399Ciphergen enters China through distribution agreement with company.bunn-1/17/2006
398[Biomarker discovery for ovarian cancer using SELDI-TOF-MS] >>Gynecol Onctuck-1/13/2006
397[Proteomic analysis of prostate cancer using SELDI] >>Zhonghua Yi Xue Za tuck-1/13/2006
396Quest & Ciphergen are both making presentations at a Diagnostics Conference bunn-1/12/2006
395[Suppression of proteolysis in serum samples after collection is NOT a good thintuck-1/9/2006
394I'm glad Ciphergen is clearing out non-producers like Martin Verhoff. Betterbunn-1/6/2006
393Somewhat old links to interesting articles: muhc.ca and bioscienceworld.ca Wrexx-12/30/2005
392Short Interest in Ciph lowest level in over one year. Dec 15 short interest is 4bunn-12/28/2005
391Nice numbers in this study for prostate cancer if validated: >>Asian J Antuck-12/27/2005
390Bill Rich did a much better job then the current stock reflects. I'm sittingbunn-12/23/2005
389Ciphergen finally squares up the accounts, while CEO Rich retires and Gail Page tuck-12/22/2005
388>>FREMONT, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, tuck-12/15/2005
387[Inflammatory protein profile during systemic high dose interleukin-2 administratuck-12/14/2005
386[Standardization of calibration and quality control using SELDI] >>Clin Ctuck-12/9/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News